HIF1A and cancer: Many HIF-1 inhibitors have been generated in the last several years, most of which function by altering signal transduction pathways that are indirectly associated with HIF or that are part of more complex pathways relevant to human cancer, clearly limiting their specificity of action and increasing their likelihood of toxicity [10,16,17].